PERRIGO COMPANY PLC (PRGO)

Price$10.76

Value ScoreA

Growth ScoreD

Momentum ScoreD

Favorite Metrics

Price vs S&P 500 (26W)-25.80%

Price vs S&P 500 (4W)-12.27%

VGM Score46.39

Market Capitalization$1.53B

Indicated Dividend Yield (Annual)10.50%

All Metrics

P/CF (Annual)6.41x

Book Value / Share (Quarterly)$18.09

P/TBV (Annual)3.31x

Indicated Dividend (Annual)$1.16

Revenue Growth (3Y)-1.51%

Cash Flow / Share (Quarterly)$0.78

Payout Ratio (TTM)532.00%

Price vs S&P 500 (YTD)-31.55%

Gross Margin (TTM)34.17%

Net Profit Margin (TTM)-43.50%

EPS (TTM)$-13.19

10-Day Avg Trading Volume2.54M

EPS Excl Extra (TTM)$-13.19

Revenue Growth (5Y)0.79%

EPS (Annual)$-10.29

Dividend / Share (Annual)$1.16

ROI (Annual)-21.68%

Gross Margin (Annual)35.14%

Net Profit Margin (5Y Avg)-8.51%

Cash / Share (Quarterly)$2.59

Revenue Growth QoQ (YoY)-7.16%

ROA (Last FY)-16.70%

Revenue Growth TTM (YoY)-3.62%

EBITD / Share (TTM)$-8.69

ROE (5Y Avg)-11.41%

Operating Margin (TTM)-36.92%

Cash Flow / Share (Annual)$1.05

P/B Ratio0.61x

P/B Ratio (Quarterly)0.54x

Net Income / Employee (Annual)$-176,000

EV / Revenue (TTM)1.15x

Net Interest Coverage (TTM)-6.98x

ROA (TTM)-19.81%

EV / EBITDA (TTM)7.88x

EPS Incl Extra (Annual)$-10.29

Current Ratio (Annual)2.76x

Quick Ratio (Quarterly)1.36x

3-Month Avg Trading Volume3.03M

52-Week Price Return-59.27%

EV / Free Cash Flow (Annual)33.11x

Revenue / Employee (TTM)$515,900

Tangible BV / Share (Quarterly)$1.70

P/S Ratio (Annual)0.36x

Asset Turnover (Annual)0.50x

52-Week High$28.43

Operating Margin (5Y Avg)-1.99%

EPS Excl Extra (Annual)$-10.29

CapEx CAGR (5Y)-14.60%

Tangible BV CAGR (5Y)-26.39%

26-Week Price Return-9.87%

Quick Ratio (Annual)1.44x

13-Week Price Return-22.13%

Total Debt / Equity (Annual)1.24x

Current Ratio (Quarterly)2.72x

Enterprise Value$4.80B

Revenue / Share Growth (5Y)0.44%

Asset Turnover (TTM)0.46x

Book Value / Share Growth (5Y)-12.88%

Revenue / Employee (Annual)$525,100

Inventory Turnover (Annual)2.47x

Pretax Margin (Annual)-30.52%

Cash / Share (Annual)$3.86

3-Month Return Std Dev54.81%

Gross Margin (5Y Avg)34.68%

Net Income / Employee (TTM)$-224,400

EBITDA CAGR (5Y)-8.13%

EBITDA Interim CAGR (5Y)-3.50%

ROE (Last FY)-48.56%

Net Interest Coverage (Annual)-9.39x

EPS Basic Excl Extra (Annual)$-10.29

P/FCF (TTM)6.50x

Receivables Turnover (TTM)5.62x

EV / Free Cash Flow (TTM)44.61x

Total Debt / Equity (Quarterly)1.45x

EPS Incl Extra (TTM)$-13.19

Receivables Turnover (Annual)6.37x

ROI (TTM)-25.14%

Dividend Growth Rate (5Y)4.76%

P/S Ratio (TTM)0.37x

Pretax Margin (5Y Avg)-5.88%

Revenue / Share (Annual)$30.71

Tangible BV / Share (Annual)$4.21

Forward P/E5.01x

Free OCF CAGR (5Y)-19.55%

Price vs S&P 500 (52W)-87.48%

Year-to-Date Return-20.62%

5-Day Price Return-1.52%

EPS Normalized (Annual)$-10.29

ROA (5Y Avg)-4.11%

Net Profit Margin (Annual)-33.51%

Month-to-Date Return-6.67%

Cash Flow / Share (TTM)$2.81

EBITD / Share (Annual)$-5.91

Operating Margin (Annual)-27.18%

LT Debt / Equity (Annual)1.22x

P/CF (TTM)8.07x

ROI (5Y Avg)-5.27%

LT Debt / Equity (Quarterly)1.44x

EPS Basic Excl Extra (TTM)$-13.19

P/TBV (Quarterly)5.70x

P/B Ratio (Annual)0.65x

Dividend / Share (TTM)$1.15

Inventory Turnover (TTM)2.42x

Pretax Margin (TTM)-41.03%

Book Value / Share (Annual)$21.33

Price vs S&P 500 (13W)-31.87%

Dividend Yield (TTM)10.37%

Beta0.51x

P/FCF (Annual)10.54x

Revenue / Share (TTM)$30.13

ROE (TTM)-50.65%

52-Week Low$9.22

vGradeA

gGradeD

mGradeD

vgmGradeC

Show chart for

Earnings Surprise History

Q1 260.43est. 0.32

Analyst Recommendations

Feb 2026

Mar 2026

Apr 2026

May 2026

3.80

Industry Peers — Pharmaceuticals(550)

Symbol	Value Score	Growth Score	Momentum Score	Price
PRGOPERRIGO COMPANY PLC	A	D	D	$10.76
LLYEli Lilly & Co.	D	B	B	$1082.20
JNJJohnson & Johnson	C	C	C	$223.51
ABBVABBVIE INC.	D	C	C	$212.93
MRKMerck & Co., Inc.	C	C	C	$115.17
NVSNovartis AG	C	C	C	$145.68
AZNAstraZeneca PLC	D	B	C	$179.71
NVONovo-Nordisk A/S	B	B	C	$44.07
PFEPfizer Inc.	B	C	C	$25.63
ABTAbbott Laboratories	C	C	D	$87.78
TEVATeva Pharmaceutical Industries Limited American Depositary Shares	C	C	C	$34.64

About

Perrigo is a global consumer health company specializing in self-care products. Its North American business, representing approximately two-thirds of sales, operates as a major private-label supplier to retailers including Walmart, Amazon, Costco, and CVS. Internationally, it markets branded products—including Compeed, Solpadeine, Coldrex, and ellaOne—in Europe, Australia, and select Asian markets. The dual strategy balances high-volume private-label revenue with branded product margins.